Core PCE inflation, the Federal Reserve's preferred gauge of inflation, rose by 4.6% year on year in February 2023, the lowest rate in 15 months and below market expectations of a rise 4.7%.
Core PCE prices rose by 0.3% month over month, following a 0.5% surge in January and falling short of market expectations of 0.4%.
Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that the company has not yet been provided with results from the company's GCP (Good Clinical Practice) vendors supporting
Consumer Portfolio Servs (NASDAQ:CPSS) reported quarterly earnings of $0.91 per share. This is a 133.33 percent increase over earnings of $0.39 per share from the same period last year. The company reported $82.00